Old Web
English
Sign In
Acemap
>
Paper
>
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life
Reduced dose of cabazitaxel in metastatic castration-resistant prostate cancer: from PROSELICA trial to the real life
2019
Giacomo Vallome
Carlo Cattrini
Carlo Messina
Luigi Cerbone
Francesco Boccardo
Elisa Zanardi
Keywords:
Molecular biology
Castration
Oncology
Cabazitaxel
Prostate cancer
Internal medicine
Medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]